SDGR Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Schrodinger Inc (SDGR) is not a strong buy at the moment for a beginner investor with a long-term strategy. The company is facing declining financial performance, insider selling, and mixed analyst ratings. While the options data shows a slightly bullish sentiment, there are no significant positive catalysts or proprietary trading signals to support an immediate buy decision. Holding off for now and monitoring the stock's performance and financial recovery is recommended.
The MACD is positive but contracting, indicating weakening upward momentum. The RSI is neutral at 44.019, and moving averages are converging, showing no clear trend. The stock is trading near its pivot level of 12.47, with key resistance at 13.012 and support at 11.927.
The company is focusing on talent acquisition and employee retention through stock options and RSUs. The biotech sector is expected to perform well in 2026, which could benefit Schrodinger in the long term.
Analyst price targets have been lowered, reflecting concerns about near-term revenue pressure.
In Q4 2025, revenue dropped by -1.23% YoY to $87.24M. Net income plunged by -180.84% YoY to $32.51M, and EPS fell by -180.00% YoY to 0.44. Gross margin decreased to 65.68%, down -9.54% YoY. These figures indicate significant financial challenges.
Analyst ratings are mixed. UBS and Morgan Stanley have Neutral and Equal Weight ratings, respectively, while BofA and TD Cowen maintain Buy ratings but have lowered their price targets. Analysts highlight concerns about near-term revenue pressure and competition but acknowledge potential long-term growth opportunities.
